Shire Rating Reiterated by JPMorgan Chase & Co. (SHP)
Shire (LON:SHP)‘s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a report released on Tuesday, American Banking News.com reports. They currently have a GBX 3,400 ($56.02) price target on the stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 12.06% from the stock’s previous close.
A number of other firms have also recently commented on SHP. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Shire in a research note to investors on Monday. They now have a GBX 3,370 ($55.53) price target on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Shire in a research note to investors on Friday. They now have a GBX 3,850 ($63.44) price target on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Shire in a research note to investors on Thursday, January 23rd. They now have a GBX 3,200 ($52.73) price target on the stock. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of GBX 2,554.86 ($42.10).
Shares of Shire (LON:SHP) traded up 2.99% during mid-day trading on Tuesday, hitting GBX 3034.00. The stock had a trading volume of 1,553,440 shares. Shire has a 52-week low of GBX 1853.0001 and a 52-week high of GBX 3040.00. The stock has a 50-day moving average of GBX 2869. and a 200-day moving average of GBX 2615.93. The company’s market cap is £16.638 billion.
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.